Work

Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes hormone-resistant prostate cancer cells to apoptotic agents.

Year: 1997

Type: article

Source: PubMed

Authors: T Dorai, E T Goluboff, C A Olsson, R Buttyan

Institution: Columbia University

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W127153085

FWCI: 1.778

Cites:

Cited by: 43

Related to: 10